Audrey MOLE

Clinical Development Head

Audrey spent over 20 years managing early and late phase clinical trials in various therapeutic areas. She has extensive experience in global clinical operations for all type of international trials (including phases I, II, III & Investigator-Initiated Studies).

Audrey is passionate in leading and working as part of collaborative clinical teams, always ensuring that ethical standards are upheld. Audrey coordinates clinical study-level activities to ensure the successful execution of trials.

Recently, Audrey joined Nexbiome Therapeutics, where she is dedicated to clinical strategy and development, with a focus on improving patient’s health.